Monday, May 14, 2018

This disease-hunting startup wants to make CRISPR tech more precise

Fast Company
This disease-hunting startup wants to make CRISPR tech more precise
This disease-hunting startup wants to make CRISPR tech more precise

Beam Therapeutics is making base editing a commercial reality.

A new Massachusetts-based startup called Beam Therapeutics launched today, and while the world is used to Harvard geniuses opening tech companies, this one is a little different. The company will be the first to go after diseases with the next generation of CRISPR tech, so-called base editing.

Read Full Story